| Title |
Tocilizumab in the treatment of rheumatoid arthritis and beyond
|
|---|---|
| Published in |
Drug Design, Development and Therapy, March 2014
|
| DOI | 10.2147/dddt.s41437 |
| Pubmed ID | |
| Authors |
Anjali Shetty, Rebekah Hanson, Peter Korsten, Munir Shawagfeh, Shiva Arami, Suncica Volkov, Olga Vila, William Swedler, Abdel Naser Shunaigat, Sameer Smadi, Ray Sawaqed, David Perkins, Shiva Shahrara, Nadera J Sweiss |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 67% |
| Members of the public | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | <1% |
| Unknown | 118 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 16 | 13% |
| Student > Ph. D. Student | 14 | 12% |
| Other | 13 | 11% |
| Researcher | 12 | 10% |
| Student > Master | 8 | 7% |
| Other | 18 | 15% |
| Unknown | 38 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 37% |
| Agricultural and Biological Sciences | 11 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 7% |
| Immunology and Microbiology | 7 | 6% |
| Biochemistry, Genetics and Molecular Biology | 4 | 3% |
| Other | 5 | 4% |
| Unknown | 40 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2023.
All research outputs
#3,257,967
of 25,584,565 outputs
Outputs from Drug Design, Development and Therapy
#182
of 2,254 outputs
Outputs of similar age
#31,505
of 236,752 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 18 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,254 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.